Herceptin 150 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FU608
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,142
Award facts
- Contract value 100% obligated
- $28,142.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Herceptin 150 mg vials with a ceiling value of $28,142.10 under a firm fixed price contract. The award was made on December 10, 2025, with an ultimate completion date of January 2, 2026. This delivery order represents a non-competitive award against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as the primary pharmaceutical supply vehicle for military healthcare systems. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
Herceptin (trastuzumab) is a specialized oncology medication used in cancer treatment, reflecting the breadth of pharmaceutical products AmerisourceBergen supplies to support military and veteran healthcare needs. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen maintains extensive capabilities across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This delivery order exemplifies the company's role in fulfilling the Defense Health Agency's pharmaceutical procurement requirements through its comprehensive global prime vendor contract, which enables rapid access to brand-name and generic medications essential for military medical operations.
Quick answers
Who was awarded contract SPE2DR26FU608?
SPE2DR26FU608 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FU608 worth?
The government has obligated $28,142 on SPE2DR26FU608.
Is contract SPE2DR26FU608 an order under another contract?
Yes. SPE2DR26FU608 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU608 competed?
The extent of competition for SPE2DR26FU608 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award